FGFs and FGFRs are often implicated in the pathogenesis of cancer. Abnormal FGF signaling can result from gene mutations, amplifications, or overexpression, leading to uncontrolled cell proliferation, resistance to apoptosis, and enhanced angiogenesis. These aberrations contribute to the development and progression of various tumor types.
